Accuray | ARAY - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
Abbott USD 1.85B 399M 2026-03
Accuray USD 4.71M 6.86M 2024-12
AngioDynamics USD -2.51M 5.41M 2025-09
Artivion USD 4.79M 6.85M 2025-12
AtriCure USD 526K 1.96M 2026-03
Boston Scientific USD 1.05B 190M 2026-03
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Inogen USD -7.79M 728K 2024-09
Mesa Laboratories USD 5.78M 2.27M 2024-12
Orthofix International USD 6.12M 1.91M 2025-12
Surmodics USD 58K 5.7M 2025-06
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Trinity Biotech USD -509K 6.27M 2025-09